Showing results (211-220 of 220) with videos related to
Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Human Gene Therapy|August 4, 2001
Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epitheliumM A Perricone, J E Morris, K Pavelka, et al.Gene Therapy|February 12, 1998
Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteersS L Chadwick, H D Kingston, M Stern, et al.Human Gene Therapy|April 10, 1997
Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lungR K Scheule, J A St George, R G Bagley, et al.Leukemia|July 1, 2017
Preclinical modeling of myelodysplastic syndromesK Rouault-Pierre, S A Mian, M Goulard, et al.Leukemia|October 31, 2015
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromesD A Sallman, R Komrokji, C Vaupel, et al.Journal of Virology|December 1, 1996
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrenceK M Hehir, D Armentano, L M Cardoza, et al.Human Gene Therapy|September 10, 1996
Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lungE R Lee, J Marshall, C S Siegel, et al.Nature|July 7, 2009
The AP-1 transcription factor Batf controls T(H)17 differentiationBarbara U Schraml, Kai Hildner, Wataru Ise, et al.Lancet (London, England)|August 25, 1999
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trialE W Alton, M Stern, R Farley, et al.Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.Pageof 22